Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression.

Korte-Bouws GAH, Albers E, Voskamp M, Hendriksen H, de Leeuw LR, Güntürkün O, de Roock S, Vastert SJ, Korte SM.

Pharmaceuticals (Basel). 2019 Jan 8;12(1). pii: E9. doi: 10.3390/ph12010009.

2.

Bacterial Lipopolysaccharide Increases Serotonin Metabolism in Both Medial Prefrontal Cortex and Nucleus Accumbens in Male Wild Type Rats, but Not in Serotonin Transporter Knockout Rats.

Korte-Bouws GAH, van Heesch F, Westphal KGC, Ankersmit LMJ, van Oosten EM, Güntürkün O, Korte SM.

Pharmaceuticals (Basel). 2018 Jul 5;11(3). pii: E66. doi: 10.3390/ph11030066.

3.

The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and "waiting" impulsivity, but increases "stopping" impulsivity.

Korte SM, Prins J, Van den Bergh FS, Oosting RS, Dupree R, Korte-Bouws GA, Westphal KG, Olivier B, Denys DA, Garland A, Güntürkün O.

Eur J Pharmacol. 2017 Jan 5;794:257-269. doi: 10.1016/j.ejphar.2016.11.024. Epub 2016 Nov 17.

PMID:
27866999
4.

Stress and laterality - The comparative perspective.

Ocklenburg S, Korte SM, Peterburs J, Wolf OT, Güntürkün O.

Physiol Behav. 2016 Oct 1;164(Pt A):321-9. doi: 10.1016/j.physbeh.2016.06.020. Epub 2016 Jun 16. Review.

PMID:
27321757
5.

The links between chronic obstructive pulmonary disease and comorbid depressive symptoms: role of IL-2 and IFN-γ.

Rybka J, Korte SM, Czajkowska-Malinowska M, Wiese M, Kędziora-Kornatowska K, Kędziora J.

Clin Exp Med. 2016 Nov;16(4):493-502. Epub 2015 Sep 24.

6.

The many different faces of major depression: it is time for personalized medicine.

Korte SM, Prins J, Krajnc AM, Hendriksen H, Oosting RS, Westphal KG, Korte-Bouws GA, Olivier B.

Eur J Pharmacol. 2015 Apr 15;753:88-104. doi: 10.1016/j.ejphar.2014.11.045. Epub 2015 Jan 12. Review.

PMID:
25592320
7.

The olfactory bulbectomy model in mice and rat: one story or two tails?

Hendriksen H, Korte SM, Olivier B, Oosting RS.

Eur J Pharmacol. 2015 Apr 15;753:105-13. doi: 10.1016/j.ejphar.2014.10.033. Epub 2014 Nov 7. Review.

PMID:
25446558
8.

Dietary long chain n-3 polyunsaturated fatty acids prevent impaired social behaviour and normalize brain dopamine levels in food allergic mice.

de Theije CG, van den Elsen LW, Willemsen LE, Milosevic V, Korte-Bouws GA, Lopes da Silva S, Broersen LM, Korte SM, Olivier B, Garssen J, Kraneveld AD.

Neuropharmacology. 2015 Mar;90:15-22. doi: 10.1016/j.neuropharm.2014.11.001. Epub 2014 Nov 12.

PMID:
25445491
9.

Serotonin release in the caudal nidopallium of adult laying hens genetically selected for high and low feather pecking behavior: an in vivo microdialysis study.

Kops MS, Kjaer JB, Güntürkün O, Westphal KG, Korte-Bouws GA, Olivier B, Bolhuis JE, Korte SM.

Behav Brain Res. 2014 Jul 15;268:81-7. doi: 10.1016/j.bbr.2014.03.050. Epub 2014 Apr 8.

PMID:
24720936
10.

Lipopolysaccharide increases degradation of central monoamines: an in vivo microdialysis study in the nucleus accumbens and medial prefrontal cortex of mice.

van Heesch F, Prins J, Konsman JP, Korte-Bouws GA, Westphal KG, Rybka J, Olivier B, Kraneveld AD, Korte SM.

Eur J Pharmacol. 2014 Feb 15;725:55-63. doi: 10.1016/j.ejphar.2014.01.014. Epub 2014 Jan 17.

PMID:
24444442
11.

Autistic-like behavioural and neurochemical changes in a mouse model of food allergy.

de Theije CG, Wu J, Koelink PJ, Korte-Bouws GA, Borre Y, Kas MJ, Lopes da Silva S, Korte SM, Olivier B, Garssen J, Kraneveld AD.

Behav Brain Res. 2014 Mar 15;261:265-74. doi: 10.1016/j.bbr.2013.12.008. Epub 2013 Dec 12.

PMID:
24333575
12.

Intestinal inflammation in a murine model of autism spectrum disorders.

de Theije CG, Koelink PJ, Korte-Bouws GA, Lopes da Silva S, Korte SM, Olivier B, Garssen J, Kraneveld AD.

Brain Behav Immun. 2014 Mar;37:240-7. doi: 10.1016/j.bbi.2013.12.004. Epub 2013 Dec 7.

PMID:
24321212
13.

Selection for low mortality in laying hens affects catecholamine levels in the arcopallium, a brain area involved in fear and motor regulation.

Kops MS, de Haas EN, Rodenburg TB, Ellen ED, Korte-Bouws GA, Olivier B, Güntürkün O, Korte SM, Bolhuis JE.

Behav Brain Res. 2013 Nov 15;257:54-61. doi: 10.1016/j.bbr.2013.09.035. Epub 2013 Sep 27.

PMID:
24076385
14.

Effects of feather pecking phenotype (severe feather peckers, victims and non-peckers) on serotonergic and dopaminergic activity in four brain areas of laying hens (Gallus gallus domesticus).

Kops MS, de Haas EN, Rodenburg TB, Ellen ED, Korte-Bouws GA, Olivier B, Güntürkün O, Bolhuis JE, Korte SM.

Physiol Behav. 2013 Aug 15;120:77-82. doi: 10.1016/j.physbeh.2013.07.007. Epub 2013 Jul 31.

PMID:
23911692
15.

Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice.

van Heesch F, Prins J, Korte-Bouws GA, Westphal KG, Lemstra S, Olivier B, Kraneveld AD, Korte SM.

Behav Brain Res. 2013 Sep 15;253:191-5. doi: 10.1016/j.bbr.2013.07.038. Epub 2013 Jul 26.

PMID:
23896053
16.

Relations between peripheral and brain serotonin measures and behavioural responses in a novelty test in pigs.

Ursinus WW, Bolhuis JE, Zonderland JJ, Rodenburg TB, de Souza AS, Koopmanschap RE, Kemp B, Korte-Bouws GA, Korte SM, van Reenen CG.

Physiol Behav. 2013 Jun 13;118:88-96. doi: 10.1016/j.physbeh.2013.05.018. Epub 2013 May 14.

PMID:
23685231
17.

Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study.

van Heesch F, Prins J, Konsman JP, Westphal KG, Olivier B, Kraneveld AD, Korte SM.

Brain Behav Immun. 2013 Mar;29:98-103. doi: 10.1016/j.bbi.2012.12.013. Epub 2012 Dec 28.

PMID:
23274951
18.

Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.

de Theije CG, Wu J, da Silva SL, Kamphuis PJ, Garssen J, Korte SM, Kraneveld AD.

Eur J Pharmacol. 2011 Sep;668 Suppl 1:S70-80. doi: 10.1016/j.ejphar.2011.07.013. Epub 2011 Jul 27. Review.

PMID:
21810417
19.

Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.

Prins J, Olivier B, Korte SM.

Expert Opin Investig Drugs. 2011 Aug;20(8):1107-30. doi: 10.1517/13543784.2011.594039. Epub 2011 Jun 20. Review.

PMID:
21682663
20.

The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.

Caldarone BJ, Paterson NE, Zhou J, Brunner D, Kozikowski AP, Westphal KG, Korte-Bouws GA, Prins J, Korte SM, Olivier B, Ghavami A.

J Pharmacol Exp Ther. 2010 Dec;335(3):762-70. doi: 10.1124/jpet.110.174011. Epub 2010 Sep 23.

Supplemental Content

Loading ...
Support Center